SEE Impact Study of the German MedTech Industry
Bundesverband Medizintechnologie e.V. (German Medical Technology Association)
Quantifying The Economic Impact of Companies
Value Balancing Alliance and WifOR Institute
Impact measurement using the Value Balancing Allicance (VBA) method
WifOR
COVID-19 Policy Environment and the Importance of Health Economy in Latin America
FIFARMA
WifOR and Value Balancing Alliance Joint Statement
Value Balancing Alliance and WifOR
The Burden of Cardiovascular Diseases in Germany
Novartis
Towards a Health Economy Policy – A Consolidated Economic and Health Policy Approach
School of International Business and Entrepreneurship (SIBE) and WifOR
The Case of Monetary Valuation
Value Balancing Alliance, Harvard Business School, WifOR and 7 others
International Benchmarking Study Berlin-Brandenburg Healthcare Industry Cluster
SNPC
Economic Impact of the Health Economy Cluster in Hamburg
Behörde für Arbeit, Gesundheit, Soziales, Familie und Integration (Sozialbehörde) Hamburg
If We Can’t Measure It, We Can’t Fix It
G20HDP, Harvard University, and WifOR
Novartis in Society: ESG Report 2020
Value of Medicines in Ireland
Irish Pharmaceutical Healthcare Association (IPHA)
Burden of Childhood Pneumonia
Social Impact of Innovative Medicines
Impact Assessment and Input-Output Tables: Data Selection
Measuring the Economic Footprint of the Biotechnology Industry in Europe
EuropaBio
Importance of Research and Development Investments in the Industrial Health Sector
Federation of German Industries (BDI)
The Global Economic Impact of the Pharmaceutical Industry
IFPMA
Direct Gross Value Added Calculation Method
The Social Impact of Tubeho Neza Program in Rwanda
The Economic Footprint of the Health Economy in Selected Latin American Countries
The Economic Footprint of the Health Economy in Mexico
The Economic Footprint of the Health Economy in Argentina
The Economic Footprint of the Health Economy in Brazil
The Economic Footprint of the Health Economy in Colombia
The Societal Impact of Lenalidomide
Celgene Germany
Key Economic Figures of the Health Economy in Hesse
Initiative Gesundheitsindustrie Hessen
The Global Economic Impact of Novartis
The Social Impact of Novartis medicines – Two Case Studies from South Africa and Kenya
The Environmental Impact of Novartis Along Global Supply Chains
Employment Insurance – Costs and Benefits
Friedrich Ebert Stiftung
The Economic Footprint of Selected Pharmaceutical Companies in Europe
Efpia
Supporting the Value Proposition of the Pharmaceutical Industry in Mexico
AMIIF
The Influence of Digitalisation on the Labour Situation in Germany
PwC
The Economic Footprint of the Cluster Life Science Nord
Life Science Nord
National Health Account for Germany
Bundesministerium für Wirtschaft und Energie (BMWi)
A Step in a New Direction? The Effect of the Parent’s Money Reform of 2007 on Employment Rates of Mothers in Germany
SOEP